Product Reports Resources Pricing Login Book a demo

Trinity Biotech

Biotech & Life Sciences · Bray, Ireland · Founded 1992 · IPO 1992

The quality of our products is essential to ensure clinicians & patients are provided with a safe and reliable diagnosis

Valuation $141M
Revenue $44M

Talent graph

Trinity Biotech's talent

Book a demo to see the people
Employees mapped 381 incl. 3 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 10 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Where Trinity Biotech has talent and traffic

Workforce by country
15 countries with
team presence
🇮🇪 Ireland50.2%
🇺🇸 United States32.7%
🇧🇷 Brazil5.8%
🇬🇧 United Kingdom1.9%
🇿🇦 South Africa1.6%
Top 5 of 15 shown
Web traffic by country
4.8K monthly visits
across markets
🇺🇸 United States91.7%
🇬🇧 United Kingdom29.2%
🇮🇪 Ireland25%
🇮🇳 India20.8%
🇨🇦 Canada14.6%
Top 5 markets shown

Patent intelligence

$28M patent portfolio · 39 active families

Estimated portfolio value
$28M
20.1% of market cap · comparable to top peer GenMark Diagnostics ($37M)
39 active patent families
Where Trinity Biotech innovates AnalyteBio sensorBiomedical engineeringBiosensorChemistry

Where Trinity Biotech concentrates vs peers

Each axis is a top-10 topic across Trinity Biotech and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Capital deployed

Trinity Biotech's 6 investments and acquisitions.

Every disclosed deal where Trinity Biotech appeared as a backer or acquirer, 2013–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

6 deals across Trinity Biotech's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        02 · Portfolio market map

        Trinity Biotech's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        6 of 6 deals

        Market sentiment

        What the market is saying about Trinity Biotech

        An AI-synthesized read of the highest-engagement posts about Trinity Biotech on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Trinity Biotech on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.